To address some of these limitations and to further understand the specificity of MAGE-C1/CT7 expression in the context of myeloma, our study initially utilized publicly available scRNA-seq datasets to confirm the expression profile of MAGE-C1/CT7 in myeloma cells. Here, MAGEC1 is linked to plasma cell myeloma.